Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 167
Filter
2.
Psychol Med ; 48(4): 693, 2018 03.
Article in English | MEDLINE | ID: mdl-28716160

Subject(s)
Biometry , Animals , Cats , Humans
3.
Mol Psychiatry ; 13(5): 470-9, 2008 May.
Article in English | MEDLINE | ID: mdl-18268502

ABSTRACT

The infectious theory of psychosis, prominent early in the twentieth century, has recently received renewed scientific support. Evidence has accumulated that schizophrenia and bipolar disorder are complex diseases in which many predisposing genes interact with one or more environmental agents to cause symptoms. The protozoan Toxoplasma gondii and cytomegalovirus are discussed as examples of infectious agents that have been linked to schizophrenia and in which genes and infectious agents interact. Such infections may occur early in life and are thus consistent with neurodevelopmental as well as genetic theories of psychosis. The outstanding questions regarding infectious theories concern timing and causality. Attempts are underway to address the former by examining sera of individuals prior to the onset of illness and to address the latter by using antiinfective medications to treat individuals with psychosis. The identification of infectious agents associated with the etiopathogenesis of schizophrenia might lead to new methods for the diagnosis, treatment and prevention of this disorder.


Subject(s)
Communicable Diseases/complications , Psychotic Disorders/etiology , Adolescent , Adult , Animals , Antibodies, Viral/blood , Bipolar Disorder/etiology , Bipolar Disorder/genetics , Bipolar Disorder/immunology , Cats , Cytomegalovirus Infections/complications , Cytomegalovirus Infections/epidemiology , Cytomegalovirus Infections/immunology , Encephalitis, Viral/complications , Female , Genetic Predisposition to Disease , Humans , Infant, Newborn , Male , Neurosyphilis/complications , Pregnancy , Pregnancy Complications, Infectious , Prenatal Exposure Delayed Effects , Rats , Risk-Taking , Schizophrenia/epidemiology , Schizophrenia/etiology , Schizophrenia/genetics , Schizophrenia/immunology , Toxoplasmosis/complications , Toxoplasmosis/immunology , Toxoplasmosis, Animal , Urban Health
4.
J Neural Transm (Vienna) ; 114(8): 1055-63, 2007.
Article in English | MEDLINE | ID: mdl-17370106

ABSTRACT

The human endogenous cannabinoid system is an appealing target in the investigation of psychiatric disorders. In schizophrenia, endocannabinoids and their receptors are involved in the pathology of the disease. Previous studies reported an increased radioligand binding to cannabinoid receptors 1 (CB(1)) in schizophrenia, both in the dorsolateral prefrontal cortex and in the anterior cingulate cortex (ACC). We analyzed the expression of the CB(1) receptors in the ACC at the protein level using immunohistochemistry. In a quantitative postmortem study, 60 patients suffering from schizophrenia, bipolar disorder, major depression and controls were included. Numerical densities of neurons and glial cells immunopositive for CB(1) receptors were evaluated. No evidence of an increased or decreased density of CB(1) receptor immunopositive cells in schizophrenia or bipolar disorder was found. In major depression, CB(1) receptor immunopositive glial cells in the grey matter were decreased. Furthermore, our data show that different medications have an impact on the expression of CB(1) receptors in the ACC.


Subject(s)
Bipolar Disorder/metabolism , Cannabinoid Receptor Modulators/metabolism , Depressive Disorder, Major/metabolism , Gyrus Cinguli/metabolism , Receptor, Cannabinoid, CB1/metabolism , Schizophrenia/metabolism , Adult , Aged , Biomarkers/analysis , Biomarkers/metabolism , Bipolar Disorder/diagnosis , Bipolar Disorder/physiopathology , Depressive Disorder, Major/diagnosis , Depressive Disorder, Major/physiopathology , Down-Regulation/physiology , Female , Gyrus Cinguli/physiopathology , Humans , Immunohistochemistry , Male , Middle Aged , Neuroglia/metabolism , Neurons/metabolism , Receptor, Cannabinoid, CB1/analysis , Schizophrenia/diagnosis , Schizophrenia/physiopathology , Substance-Related Disorders/diagnosis , Substance-Related Disorders/metabolism , Substance-Related Disorders/physiopathology
5.
Proc Biol Sci ; 273(1589): 1023-30, 2006 Apr 22.
Article in English | MEDLINE | ID: mdl-16627289

ABSTRACT

With increasing pressure to understand transmissible agents, renewed recognition of infectious causation of both acute and chronic diseases is occurring. Epidemiological and neuropathological studies indicate that some cases of schizophrenia may be associated with environmental factors, such as exposure to the ubiquitous protozoan Toxoplasma gondii. Reasons for this include T. gondii's ability to establish persistent infection within the central nervous system, its ability to manipulate intermediate host behaviour, the occurrence of neurological and psychiatric symptoms in some infected individuals, and an association between infection with increased incidence of schizophrenia. Moreover, several of the medications used to treat schizophrenia and other psychiatric disease have recently been demonstrated in vitro to possess anti-parasitic, and in particular anti-T. gondii, properties. Our aim here was thus to test the hypothesis that the anti-psychotic and mood stabilizing activity of some medications may be achieved, or at least augmented, through their in vivo inhibition of T. gondii replication and invasion in infected individuals. In particular we predicted, using the epidemiologically and clinically applicable rat-T. gondii model system, and following a previously described and neurologically characterized 'feline attraction' protocol that haloperidol (an anti-psychotic used in the treatment of mental illnesses including schizophrenia) and/or valproic acid (a mood stabilizer used in the treatment of mental illnesses including schizophrenia), would be, at least, as effective in preventing the development of T. gondii-associated behavioural and cognitive alterations as the standard anti-T. gondii chemotherapeutics pyrimethamine with Dapsone. We demonstrate that, while T. gondii appears to alter the rats' perception of predation risk turning their innate aversion into a 'suicidal' feline attraction, anti-psychotic drugs prove as efficient as anti-T. gondii drugs in preventing such behavioural alterations. Our results have important implications regarding the aetiology and treatment of such disorders.


Subject(s)
Antimanic Agents/therapeutic use , Antiprotozoal Agents/therapeutic use , Antipsychotic Agents/therapeutic use , Mood Disorders/parasitology , Toxoplasma/drug effects , Animals , Behavior, Animal/drug effects , Cats , Dapsone/therapeutic use , Haloperidol/therapeutic use , Humans , Mood Disorders/prevention & control , Pyrimethamine/therapeutic use , Rabbits , Rats , Toxoplasma/pathogenicity , Toxoplasmosis, Animal/complications , Toxoplasmosis, Animal/drug therapy , Valproic Acid/therapeutic use
6.
Psychopathology ; 38(2): 87-90, 2005.
Article in English | MEDLINE | ID: mdl-15855832

ABSTRACT

OBJECTIVE: Environmental factors such as infectious agents may contribute to the psychopathology and aetiology of schizophrenia. Toxoplasma gondii (TG) is a candidate infectious agent as it is known to replicate within the human central nervous system and to alter behaviour in experimental animals. METHOD: The relationship between antibodies to TG and psychopathological symptoms was examined in 34 first-episode patients with schizophrenia. RESULTS: Results of regression analyses revealed that symptoms on admission, predictors of outcome, age and family history of psychiatric disease influenced the levels of antibodies to TG. CONCLUSIONS: These results indicate that TG infections may play a role in the clinical manifestation of psychopathology in a subgroup of patients with schizophrenia.


Subject(s)
Immunoglobulin G/immunology , Immunoglobulin M/immunology , Schizophrenia/immunology , Schizophrenia/parasitology , Toxoplasma/immunology , Toxoplasmosis/microbiology , Adolescent , Adult , Animals , Blotting, Western , Female , Humans , Immunoenzyme Techniques , Immunoglobulin A/immunology , Male , Middle Aged , Schizophrenia/blood , Time Factors , Toxoplasmosis/immunology
7.
J Neural Transm (Vienna) ; 112(2): 297-302, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15657644

ABSTRACT

Homocysteine is a neurotoxic amino acid originally found to be an independent risk factor for cardiovascular and cerebral vascular disease and more recently suggested to be a risk factor for Alzheimer's disease. Several authors have observed high plasma homocysteine levels among schizophrenia patients. We reported that such high levels characterize young male schizophrenia patients. We now studied two groups of schizophrenia patients (N=41) and controls (N=29) for CSF homocysteine levels. No difference was found for CSF homocysteine levels between schizophrenia patients and controls (p=.041 for Study A and p=.52 for Study B).


Subject(s)
Homocysteine/cerebrospinal fluid , Schizophrenia/cerebrospinal fluid , Adolescent , Adult , Female , Humans , Male , Middle Aged
8.
Mol Psychiatry ; 9(7): 684-97, 643, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15098003

ABSTRACT

The etiology and pathophysiology of schizophrenia remain unknown. A parallel transcriptomics, proteomics and metabolomics approach was employed on human brain tissue to explore the molecular disease signatures. Almost half the altered proteins identified by proteomics were associated with mitochondrial function and oxidative stress responses. This was mirrored by transcriptional and metabolite perturbations. Cluster analysis of transcriptional alterations showed that genes related to energy metabolism and oxidative stress differentiated almost 90% of schizophrenia patients from controls, while confounding drug effects could be ruled out. We propose that oxidative stress and the ensuing cellular adaptations are linked to the schizophrenia disease process and hope that this new disease concept may advance the approach to treatment, diagnosis and disease prevention of schizophrenia and related syndromes.


Subject(s)
Brain/metabolism , Mitochondrial Diseases/genetics , Mitochondrial Diseases/metabolism , Schizophrenia/genetics , Schizophrenia/metabolism , Fatty Acids/metabolism , Genome, Human , Glucose/metabolism , Humans , Hypoxia, Brain/etiology , Hypoxia, Brain/genetics , Hypoxia, Brain/metabolism , Mitochondrial Diseases/complications , Oligonucleotide Array Sequence Analysis , Oxidative Phosphorylation , Oxidative Stress , Proteomics , Schizophrenia/etiology , Signal Transduction
9.
Mol Psychiatry ; 7(4): 392-404, 2002.
Article in English | MEDLINE | ID: mdl-11986983

ABSTRACT

Post-mortem specimens from the Stanley Foundation Neuropathology Consortium, which contains matched samples from patients with schizophrenia, bipolar disorder, non-psychotic depression and normal controls (n = 15 per group), have been distributed to many research groups around the world. This paper provides a summary of abnormal markers found in prefrontal cortical areas from this collection between 1997 and 2001. With parametric analyses of variance of 102 separate data sets, 14 markers were abnormal in at least one disease. The markers pertained to a variety of neural systems and processes including neuronal plasticity, neurotransmission, signal transduction, inhibitory interneuron function and glial cells. The data sets were also examined using the non-parametric Classification and Regression Tree (CRT) technique for the four diagnostic groups and in pair-wise combinations. In contrast to the results obtained with analyses of variance, the CRT method identified a smaller set of nine markers that contributed maximally to the diagnostic classifications. Three of the nine markers observed with CRT overlapped with the ANOVA results. Six of the nine markers observed with the CRT technique pertained to aspects of glutamatergic, GABA-ergic, and dopaminergic neurotransmission.


Subject(s)
Mental Disorders/pathology , Prefrontal Cortex/chemistry , Prefrontal Cortex/pathology , Adult , Biomarkers , Bipolar Disorder/pathology , Decision Trees , Depressive Disorder, Major/pathology , Female , Humans , Male , Middle Aged , Neuronal Plasticity , Predictive Value of Tests , Regression Analysis , Schizophrenia/pathology
10.
Arch Gen Psychiatry ; 58(11): 1032-7, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11695949

ABSTRACT

BACKGROUND: We tested the hypothesis that maternal infections during pregnancy are associated with the subsequent development of schizophrenia and other psychoses in adulthood. METHODS: We conducted a nested case-control study of 27 adults with schizophrenia and other psychotic illnesses and 54 matched unaffected control subjects (matched for sex, ethnicity, and date of birth) from the Providence, RI, cohort of the Collaborative Perinatal Project. We retrieved stored blood samples that had been obtained from these mothers at the end of pregnancy. These samples were analyzed for total class-specific immunoglobulins and for specific antibodies directed at recognized perinatal pathogens capable of affecting brain development. RESULTS: Maternal levels of IgG and IgM class immunoglobulins before the mothers were delivered of their neonates were significantly elevated among the case series (t = 3.06, P =.003; t = 2.93, P =.004, respectively, for IgG and IgM immunoglobulin-albumin ratios). Secondary analyses indicated a significant association between maternal antibodies to herpes simplex virus type 2 glycoprotein gG2 and subsequent psychotic illness (matched t test = 2.43, P =.02). We did not find significant differences between case and control mothers in the serum levels of IgA class immunoglobulins, or in specific IgG antibodies to herpes simplex virus type 1, cytomegalovirus, Toxoplasma gondii, rubella virus, human parvovirus B19, Chlamydia trachomatis, or human papillomavirus type 16. CONCLUSIONS: The offspring of mothers with elevated levels of total IgG and IgM immunoglobulins and antibodies to herpes simplex virus type 2 are at increased risk for the development of schizophrenia and other psychotic illnesses in adulthood.


Subject(s)
Bacterial Infections/blood , Bacterial Infections/immunology , Immunoglobulin A/blood , Immunoglobulin A/immunology , Immunoglobulin G/blood , Immunoglobulin G/immunology , Immunoglobulin M/blood , Immunoglobulin M/immunology , Mothers , Psychotic Disorders/genetics , Psychotic Disorders/immunology , Virus Diseases/blood , Virus Diseases/immunology , Albumins/immunology , Antibodies, Bacterial/blood , Antibodies, Bacterial/immunology , Antibodies, Viral/blood , Antibodies, Viral/immunology , Case-Control Studies , Female , Follow-Up Studies , Humans , Infant, Newborn , Male , Pregnancy , Pregnancy Complications
11.
Brain Res Bull ; 55(5): 651-9, 2001 Jul 15.
Article in English | MEDLINE | ID: mdl-11576762

ABSTRACT

Prefrontal cortical tissue from the Stanley Foundation Neuropathology Consortium, which contains samples from patients with schizophrenia, bipolar disorder, non-psychotic depression, and normal controls (n = 15 per group), was studied in a blinded fashion in 14 different laboratories between 1997 and 2000. The results of 69 separate data sets were analyzed with univariate and multivariate techniques. A total of 17 abnormal markers were identified that pertained to a variety of neural systems and processes, including neuronal plasticity, neurotransmission, signal transduction, inhibitory interneuron function, and glial cells. Schizophrenia was associated with the largest number of abnormalities, many of which were also present in bipolar disorder. Major depression was associated with relatively few abnormalities. The majority of abnormal findings represented a decline in function and could not be easily explained by exposure to psychotropic or illicit drugs. It is argued that the abnormal findings are not simply due to stochastic processes but represent viable markers for independent replication and further study as candidate genes or targets for new treatments.


Subject(s)
Bipolar Disorder/pathology , Depressive Disorder, Major/pathology , Schizophrenia/pathology , Tissue Banks , Adult , Aged , Biomarkers/analysis , Bipolar Disorder/physiopathology , Calcium Channels/genetics , Cell Adhesion Molecules, Neuronal/genetics , Depressive Disorder, Major/physiopathology , Electron Transport Complex IV/genetics , Extracellular Matrix Proteins/genetics , Female , Humans , Male , Middle Aged , Multivariate Analysis , Nerve Tissue Proteins , RNA, Messenger/metabolism , Receptors, Dopamine D2/genetics , Reelin Protein , Schizophrenia/physiopathology , Serine Endopeptidases , Substance-Related Disorders/metabolism , Substance-Related Disorders/pathology , Substance-Related Disorders/physiopathology
12.
Br J Psychiatry Suppl ; 41: s137-41, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11450174

ABSTRACT

BACKGROUND: Bipolar disorder is a serious brain disease affecting more than a million individuals living in the USA. Epidemiological studies indicate a role for both genetic and environmental factors in the pathogenesis of this disorder. AIM: To identify RNA transcripts that are up- or down-regulated in the frontal cortex regions of individuals with bipolar disorder. METHOD: Serial analysis of gene expression (SAGE) and reverse transcriptase-polymerase chain reaction were used to identify RNA transcripts which are differentially expressed in the frontal cortex of brains obtained postmortem from individuals with bipolar disorder compared with other psychiatric and control conditions. RESULTS: Levels of RNA transcripts encoding the serotonin transporter protein and components of the NF-kappa B transcription factor complex are significantly increased in individuals with bipolar disorder compared with unaffected controls. Increased levels of expression of these RNA transcripts were also detected in the brains of some individuals with schizophrenia and unipolar depression. CONCLUSION: The SAGE technique offers promise for the characterisation of complex human brain diseases.


Subject(s)
Bipolar Disorder/metabolism , Cerebral Cortex/metabolism , Membrane Transport Proteins , Carrier Proteins/genetics , Carrier Proteins/metabolism , Gene Expression , Humans , Membrane Glycoproteins/genetics , Membrane Glycoproteins/metabolism , NF-kappa B/genetics , NF-kappa B/metabolism , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/metabolism , RNA/genetics , Reverse Transcriptase Polymerase Chain Reaction , Serotonin Plasma Membrane Transport Proteins , Transcription, Genetic
13.
Int J Neuropsychopharmacol ; 4(1): 83-92, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11343633

ABSTRACT

Neuropsychiatric diseases such as schizophrenia and bipolar disorder are major causes of morbidity throughout the world. Despite extensive searches, no single gene, RNA transcript, or protein has been found which can, on its own, account for these disorders. Recently, the availability of genomic tools such as cDNA microarrays, serial analysis of gene expression (SAGE) and large-scale sequencing of cDNA libraries has allowed researchers to assay biological samples for a large number of RNA transcripts. Similarly, proteomic tools allow for the quantitation of a large number of peptides and proteins. These methods include two-dimensional electrophoresis and surface-enhanced laser desorption/ionization (SELDI). We have initiated experiments which apply these techniques to the comparison of RNAs and proteins expressed in clinical samples obtained from individuals with psychiatric diseases and controls. These methods have the potential to identify pathways that are involved in the pathogenesis of complex psychiatric disorders. The characterization of these pathways may allow for the development of new methods for the diagnosis and treatment of schizophrenia, bipolar disorder, and other human psychiatric diseases.


Subject(s)
Gene Expression Profiling/methods , Gene Expression/genetics , Gene Library , Mental Disorders/genetics , Sequence Analysis, DNA/methods , Electrophoresis, Gel, Two-Dimensional/methods , Gene Expression Profiling/trends , Humans , Mental Disorders/cerebrospinal fluid , Peptide Mapping/methods , Peptide Mapping/trends , Schizophrenia/cerebrospinal fluid , Sequence Analysis, DNA/trends
14.
Schizophr Res ; 49(3): 295-9, 2001 Apr 30.
Article in English | MEDLINE | ID: mdl-11356590

ABSTRACT

In response to previous reports of geographical clustering of individuals with psychosis, a study was carried out in Denmark utilizing the national case register. Two-thousand one-hundred and ninety-nine (2199) individuals with schizophrenia were divided by place of birth into 217 geographical areas and analyzed by age, gender, month of birth, genetic relatedness, and degree of urbanization of birthplace. Heterogeneity was ascertained using log-linear Poisson regression. The greatest amount of heterogeneity was associated with degree of urbanization of place of birth. Heterogeneity was also associated with age-gender interaction and calendar period. When adjusted for these factors, there was no remaining heterogeneity, suggesting that all geographical clustering in our study was explained by the above factors.


Subject(s)
Schizophrenia/epidemiology , Topography, Medical/statistics & numerical data , Cluster Analysis , Denmark/epidemiology , Female , Humans , Incidence , Male , Prevalence , Risk Factors , Schizophrenia/diagnosis , Schizophrenia/etiology , Urban Population/statistics & numerical data
15.
Proc Natl Acad Sci U S A ; 98(8): 4634-9, 2001 Apr 10.
Article in English | MEDLINE | ID: mdl-11296294

ABSTRACT

Schizophrenia is a serious brain disease of uncertain etiology. A role for retroviruses in the etiopathogenesis of some cases of schizophrenia has been postulated on the basis of clinical and epidemiological observations. We found sequences homologous to retroviral pol genes in the cell-free cerebrospinal fluids (CSFs) of 10 of 35 (29%) individuals with recent-onset schizophrenia or schizoaffective disorder. Retroviral sequences also were identified in the CSFs of 1 of 20 individuals with chronic schizophrenia. However, retroviral sequences were not identified in any of the CSFs obtained from 22 individuals with noninflammatory neurological diseases or from 30 individuals without evidence of neurological or psychiatric diseases (chi(2) = 19.25, P < 0.001). The nucleotide sequences identified in the CSFs of the individuals with schizophrenia or schizoaffective disorder were related to those of the human endogenous retroviral (HERV)-W family of endogenous retroviruses and to other retroviruses in the murine leukemia virus genus. Transcription of RNA homologous to members of the HERV-W family of retroviruses also was found to be up-regulated differentially in the frontal cortex regions of brains obtained postmortem from individuals with schizophrenia, as compared with corresponding tissue from individuals without psychiatric diseases. The transcriptional activation of certain retroviral elements within the central nervous system may be associated with the development of schizophrenia in at least some individuals. The further characterization of retroviral elements within the central nervous system of individuals with schizophrenia might lead to improved methods for the diagnosis and management of this disorder.


Subject(s)
Endogenous Retroviruses/genetics , RNA, Viral/cerebrospinal fluid , Schizophrenia/virology , Adult , Aged , Base Sequence , Cloning, Molecular , DNA Primers , Humans , Middle Aged , Molecular Sequence Data , Schizophrenia/cerebrospinal fluid , Sequence Homology, Amino Acid
16.
Clin Infect Dis ; 32(5): 842-4, 2001 Mar 01.
Article in English | MEDLINE | ID: mdl-11229859

ABSTRACT

We employed enzyme immunoassay (EIA) and Western blotting techniques to measure the level of antibodies to Toxoplasma gondii proteins in serum samples from 38 individuals undergoing their first episode of schizophrenia and from a group of matched control subjects. We found that the individuals with first-episode schizophrenia had significantly increased levels of IgG, IgM, and IgA class antibodies to Toxoplasma proteins, as compared with the control subjects.


Subject(s)
Antibodies, Protozoan/blood , Schizophrenia/complications , Toxoplasma/immunology , Toxoplasmosis/complications , Adult , Animals , Antibody Specificity , Blotting, Western , Humans , Immunoenzyme Techniques , Matched-Pair Analysis , Middle Aged , Schizophrenia/immunology , Toxoplasmosis/immunology
17.
Psychiatr Serv ; 52(3): 337-41, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11239101

ABSTRACT

The authors describe studies showing the effectiveness of involuntary outpatient commitment in improving treatment compliance, reducing hospital readmission, and reducing episodes of violence among persons with severe psychiatric illnesses. They point out that because of its role in enhancing compliance with treatment, outpatient commitment can be regarded as a form of assisted treatment, such as assertive case management, representative payeeship, and mental health courts. The authors argue that such assisted treatment is necessary for persons with severe psychiatric illnesses who are noncompliant with their medication regimens because many lack awareness of their illnesses because of biologically based cognitive deficits. They recommend outpatient commitment for any individual with a severe psychiatric disorder who has impaired awareness of his or her illness and is at risk of becoming homeless, incarcerated, or violent or of committing suicide, and they provide case examples. The authors conclude by addressing eight of the most common objections to outpatient commitment by mental health professionals and civil liberties groups that oppose outpatient commitment.


Subject(s)
Civil Rights/legislation & jurisprudence , Commitment of Mentally Ill , Community Mental Health Services , Psychotic Disorders/drug therapy , Coercion , Commitment of Mentally Ill/legislation & jurisprudence , Community Mental Health Services/legislation & jurisprudence , Humans , Outcome Assessment, Health Care , Patient Compliance , Patient Readmission , United States , Violence
18.
Schizophr Res ; 47(2-3): 243-6, 2001 Mar 01.
Article in English | MEDLINE | ID: mdl-11278141

ABSTRACT

A number of studies have found that being born in an urban area is a risk factor for developing schizophrenia. It has been hypothesized that increased exposure to infectious agents through household crowding might account for this association. Using Danish longitudinal registers, we have established a population-based sample of 191 cases of schizophrenia where the first admission occurred between 1981 and 1993. These cases were compared with 17413 individually matched controls of the same gender and age. Information regarding parents' and siblings' psychiatric history, urbanization, season and place of birth, and square meter per dweller were included in a conditional logistic regression model. We found square meter per dweller to be insignificant and without any trend when included as a risk factor for schizophrenia, whereas previous findings of schizophrenia associated with being born in an urban area and with schizophrenia in parents and siblings were replicated.


Subject(s)
Family Characteristics , Housing , Population Surveillance , Schizophrenia/epidemiology , Adult , Denmark/epidemiology , Female , Humans , Male , Middle Aged , Risk Factors , Rural Population/statistics & numerical data , Urban Population/statistics & numerical data
19.
Psychiatry Res ; 106(1): 25-34, 2001 Feb 28.
Article in English | MEDLINE | ID: mdl-11231097

ABSTRACT

Six monozygotic (MZ) twin pairs discordant for bipolar disorder were compared with normal MZ twins with magnetic resonance imaging (MRI) on volumes of basal ganglia (BG), amygdala-hippocampus (AH), and cerebral hemisphere. Caudate nuclei were larger in both affected and unaffected bipolar twins than in normal MZ twins. The right hippocampus was smaller in the sick vs. well bipolar twins. The hippocampus was also less asymmetric in the affected bipolar twins than in the well cotwins and the normal MZ twins. These anatomical structures continue to be of interest in bipolar disorder research.


Subject(s)
Bipolar Disorder/diagnosis , Brain/abnormalities , Twins, Monozygotic/psychology , Adult , Amygdala/abnormalities , Basal Ganglia/abnormalities , Bipolar Disorder/epidemiology , Bipolar Disorder/psychology , Caudate Nucleus/abnormalities , Female , Functional Laterality/physiology , Hippocampus/abnormalities , Humans , Magnetic Resonance Imaging , Male
20.
Brain Behav Immun ; 15(4): 401-10, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11782106

ABSTRACT

Schizophrenia and rheumatoid arthritis share an impressive number of similarities. Both are chronic, relapsing diseases of unknown etiology. Both became prominent in the early 19th century and have prevalences of approximately 1% in North America and Europe. Both run in families, have pairwise concordance rates of approximately 30% among monozygotic twins, and are more common among individuals born in urban areas. For both diseases, studies have reported greater exposure to cats in childhood than in controls. Both diseases have been associated with similar class II HLA antigens. Both have also been suspected of having infectious etiology, with similar agents--retroviruses, herpesviruses including EBV, and Toxoplasma gondii--having been associated in some cases. Since there is also a well-documented inverse correlation between these two diseases, it is possible that they share a common infectious and/or immune etiology and that once a person gets one of the diseases then they are relatively immune to the other.


Subject(s)
Arthritis, Rheumatoid/etiology , Arthritis, Rheumatoid/immunology , Schizophrenia/etiology , Schizophrenia/immunology , Arthritis, Rheumatoid/parasitology , Histocompatibility Antigens Class II/immunology , Humans , Schizophrenia/parasitology , Toxoplasmosis/immunology , Virus Diseases/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...